390
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Combination of lipids and uric acid in mid-second trimester can be used to predict adverse pregnancy outcomes

, , &
Pages 2633-2638 | Received 02 Mar 2012, Accepted 13 Jun 2012, Published online: 13 Jul 2012

References

  • Mankuta D, Elami-Suzin M, Elhayani A, Vinker S. Lipid profile in consecutive pregnancies. Lipids Health Dis 2010;9:58.
  • Igarashi M, Miyake H, Suzuki S. Effect of changes in renal circulation on serum uric acid levels in women with twin pregnancy. Clin Exp Nephrol 2010;14:436–439.
  • Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY. Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment. Hypertension 2003;41:528–533.
  • Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, Kuo CT. Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford) 2010;49:1929–1934.
  • Qiu C, Phung TT, Vadachkoria S, Muy-Rivera M, Sanchez SE, Williams MA. Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia. Physiol Res 2006;55:491–500.
  • Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, Roberts JM. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol 2007;197:610.e1–610.e7.
  • Wolak T, Sergienko R, Wiznitzer A, Paran E, Sheiner E. High Uric Acid Level During the First 20 Weeks of Pregnancy is Associated with Higher Risk for Gestational Diabetes Mellitus and Mild Preeclampsia. Hypertens Pregnancy 2010; 31:307–315.
  • Laughon SK, Catov J, Roberts JM. Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. Am J Obstet Gynecol 2009; 201:e1–e6.
  • American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care 2009; 32 Suppl 1:S13–S16.
  • Hui A, Back L, Ludwig S, Gardiner P, Sevenhuysen G, Dean H, Sellers E, et al. Lifestyle intervention on diet and exercise reduced excessive gestational weight gain in pregnant women under a randomised controlled trial. BJOG 2012;119:70–77.
  • Martin AC, Brown MA. Could uric acid have a pathogenic role in pre-eclampsia? Nat Rev Nephrol 2010;6:744–748.
  • Lam C, Lim KH, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol 2005;25:56–60.
  • Belo L, Caslake M, Gaffney D, Santos-Silva A, Pereira-Leite L, Quintanilha A, Rebelo I. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002;162:425–432.
  • Baker AM, Klein RL, Moss KL, Haeri S, Boggess K. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol 2009;201:293.e1–293.e4.
  • Laughon SK, Catov J, Provins T, Roberts JM, Gandley RE. Elevated first-trimester uric acid concentrations are associated with the development of gestational diabetes. Am J Obstet Gynecol 2009; 201:e1–e5.
  • Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005;46:1263–1269.
  • Catarino C, Rebelo I, Belo L, Rocha-Pereira P, Rocha S, Castro EB, Patrício B, et al. Fetal lipoprotein changes in pre-eclampsia. Acta Obstet Gynecol Scand 2008;87:628–634.
  • Bayhan G, Koçyigit Y, Atamer A, Atamer Y, Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 2005;21:1–6.
  • Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Baumstark MW, Zahradnik HP, et al. Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 2003;88:1162–1166.
  • Horosz E, Bomba-Opon D, Wielgos M, Szymanska M, Bartkowiak R. Effects of maternal lipids on the fetal growth in gestational diabetes. Neuro Endocrinol Lett 2009;30:652–656.
  • Håglin L, Lundström S, Kaati G, Bäckman L, Bygren LO. All-cause mortality of patients with dyslipidemia up to 19 years after a multidisciplinary lifestyle modification programme: a randomized trial. Eur J Cardiovasc Prev Rehabil 2011;18:79–85.
  • Grover S, Coupal L, Kouache M, Lowensteyn I, Marchand S, Campbell N. Estimating the benefits of patient and physician adherence to cardiovascular prevention guidelines: the MyHealthCheckup Survey. Can J Cardiol 2011;27:159–166.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.